Thickening of the cardiac valves leads to congestive heart failure, chest pain, sudden loss of consciousness and often death. Experiments in mice now link this condition to dysregulation of an endogenous inhibitor of angiogenesis (1151–1159).
References
Folkman, J. Nat. Med. 1, 27–31 (1995).
Gariano, R.F. & Gardner, T.W. Nature 438, 960–966 (2005).
Yoshioka, M. et al. Nat. Med. 12, 1151–1159 (2006).
Nyberg, P., Xie, L. & Kalluri, R. Cancer Res. 65, 3967–3979 (2005).
Sugimoto, H. et al. J. Biol. Chem. 278, 12605–12608 (2003).
Fowble, V.A., Vigorita, V.J., Bryk, E. & Sands, A.K. Clin. Orthop. Relat. Res. 450, 225–230 (2006).
Moses, M.A. et al. Proc. Natl. Acad. Sci. USA 96, 2645–2650 (1999).
Kusafuka, K. et al. Am. J. Pathol. 158, 1465–1472 (2001).
Hayami, T. et al. FEBS Lett. 458, 436–440 (1999).
O'Brien, K.D. Arterioscler. Thromb. Vasc. Biol. 26, 1721–1728 (2006).
Dawson, D.W. et al. Science 285, 245–248 (1999).
Chalajour, F. et al. Exp. Cell Res. 298, 455–464 (2004).
Charest, A. et al. Heart, published online 18 May 2006 (doi: 10.1136/hrt.2005.086595).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kalluri, R., Zeisberg, E. Controlling angiogenesis in heart valves. Nat Med 12, 1118–1119 (2006). https://doi.org/10.1038/nm1006-1118
Issue Date:
DOI: https://doi.org/10.1038/nm1006-1118
- Springer Nature America, Inc.